In support of this model, fibroblasts associated with 4T1 tumours show a significantly increased TGFβ pathway activation compared with 4T07 tumour fibroblasts as monitored by higher phospho-Smad2 levels within the fibroblast nuclei (Fig. 5f). The gene discussed is SMAD2; the disease is neoplasm.